Research & Innovation

At the forefront of urological research and treatment, we are dedicated to enhancing patient care through innovative solutions. Explore our groundbreaking research and meet the experts who are transforming urologic health in B.C.

World-Class Research Pioneering Breakthroughs in Urologic Science

The M. H. Mohseni Institute of Urologic Science is at the forefront of cutting-edge research and technological advancements, dedicated to transforming the field of urology. Our focus spans innovative research, advanced diagnostics, and state-of-the-art technologies in key areas including prostate and bladder diseases, kidney stones, functional urology, kidney transplantation, reproductive medicine, and adolescent urology.

Highlighted Areas of Research

At the M. H. Mohseni Institute of Urologic Science, our experts lead advancements in uro-oncology, kidney stones, transplantation, sexual health, and clinical trials. From tackling treatment-resistant cancers to innovating minimally invasive techniques, our researchers are transforming urological care with cutting-edge science.

Sustained Therapeutics: A New Frontier in Drug Delivery

The Vancouver Prostate Centre has launched a clinical trial investigating a novel treatment for upper tract urothelial carcinoma (UTUC). By using sustained drug delivery, this approach enhances treatment efficacy while minimizing side effects, offering new hope for improved cancer therapies.

Pulsed Photothermal Therapy: A Smart Weapon Against Cancer

Researchers at Vancouver Coastal Health have developed a laser-based therapy that precisely targets and destroys cancer cells. This non-invasive approach not only eliminates tumors but also boosts the immune system, paving the way for safer and more effective cancer treatments.

Innovation and Spin-Off Companies

We are proud to collaborate with industry leaders to translate groundbreaking research into commercial solutions.

SnapCyte Solutions Inc – Advancing AI-driven cell analysis technology for research and clinical applications.

Sustained Therapeutics – Revolutionizing drug delivery systems for targeted and sustained therapeutic effects.

Rakovina Therapeutics – uses AI and Deep-Docking™ tech to accelerate the development of cancer treatments.

2008-2024

By the Numbers

221

Clinical Trials

Patients Enrolled

2092

Publications

1115

Trainees

Spin-offs

422

Patents Issued/Filed

Clinical Fellows

468

New/Ongoing Contract Research Agreements

Research Grants

The Mohseni Institute of Urologic Sciences

Shaping the Future of Urologic Science

With over 40 active research projects, the M. H. Mohseni Institute of Urologic Sciences remains at the cutting edge of innovation. By fostering global collaborations and integrating laboratory discoveries with clinical applications, we are dedicated to improving patient outcomes, reducing suffering, and setting new standards in urologic care. Stay informed about our latest research breakthroughs and innovations shaping the future of urology.

Explore Our Core Research Initiatives